EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic and Therapeutic Significance of Cancer‐Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single‐Cell RNA Sequencing Data

Yukang Que iD, Tianming Ding, Huming Wang, Shenglin Xu, Peng He, Qiling Shen, Kun Cao, Yang Luo, Yong Hu

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yukang Que und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Osteosarcoma, Single-Cell Analysis, Cancer-Associated Fibroblasts, Bone Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major scientific research projects of the Health Commission of Anhui Province, Research Fund of Anhui Institute of Translational Medicine, Program for Upgrading Basic and Clinical Collaborative Research of Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is the most frequent primary solid malignancy of bone, whose course is usually dismal without efficient treatments. The aim of the study was to discover novel risk models to more accurately predict and improve the prognosis of patients with osteosarcoma. The single‐cell RNA sequencing (scRNA‐seq) data was obtained from the GEO database. Bulk RNA‐seq data and microarray data of OS were obtained from the TARGET and GEO databases respectively. A clustering tree was plotted to classify all cells into different clusters. The “cellchat” R package was used to establish and visualise cell–cell interaction networks. Then Univariate COX regression analysis was used to determine the prognostic CAF‐related genes, followed by the Lasso‐Cox regression analysis to build a risk on the prognostic CAF‐related genes. Finally, from multiple perspectives, the signature was validated as an accurate and dependable tool in predicting the prognosis and guiding treatment therapies in OS patients. From the single‐cell dataset, six OS patients and 46,544 cells were enrolled. All cells were classified into 22 clusters, and the clusters were annotated to 14 types of cells. Subsequently, CAFs were observed as a vital TME components. In cell–cell interaction networks in OS cells, CAFs had a profound impact as four roles. Via the Univariate COX regression analysis, 14 CAF‐related genes were screened out. By the Lasso‐Cox regression analyses, 11 key CAF‐related genes were obtained, based on which an 11‐gene signature that could predict the prognosis of osteosarcoma patients was constructed. According to the median of risk scores, all patients were grouped in to the high‐ and low‐risk group, and their overall survival, activated pathways, immune cell infiltrations, and drug sensitivity were significantly differential, which may have important implications for the clinical treatment of patients with osteosarcoma. Our study, a systematic analysis of gene and regulatory genes, has proven that CAF‐related genes had excellent diagnostic and prognostic capabilities in OS, and it may reshape the TME in OS. The novel CAF‐related risk signature can effectively predict the prognosis of OS and provide new strategies for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaSingle-Cell AnalysisCancer-Associated FibroblastsBone NeoplasmsBiomarkers, TumorHumansPrognosisGene Expression Regulation, NeoplasticGene Expression ProfilingMaleSequence Analysis, RNAFemaleTumor MicroenvironmentGene Regulatory Networks

Stichwörter der Autor:innen

cancer‐associated fibroblastsgenesosteosarcomaprognosissingle‐cell RNA sequencing

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Orthopedics, The First Affiliated Hospital Anhui Medical University, Hefei, Anhui, China.
  • Department of Orthopedics, Yangzhou East Hospital, Yangzhou, Jiangsu, China.

ORCID-Profile: Yukang Que

Förderung

  • Major scientific research projects of the Health Commission of Anhui Province
  • Research Fund of Anhui Institute of Translational Medicine
  • Program for Upgrading Basic and Clinical Collaborative Research of Anhui Medical University

Zitieren

APA

Que, Y., Ding, T., Wang, H., Xu, S., He, P., Shen, Q., Cao, K., Luo, Y., & Hu, Y. (2025). Prognostic and Therapeutic Significance of Cancer‐Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single‐Cell RNA Sequencing Data. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70424

Vancouver

Que Y, Ding T, Wang H, Xu S, He P, Shen Q, et al. Prognostic and Therapeutic Significance of Cancer‐Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single‐Cell RNA Sequencing Data. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70424

BibTeX
@article{Que2025,
  author = {Que, Yukang and Ding, Tianming and Wang, Huming and Xu, Shenglin and He, Peng and Shen, Qiling and Cao, Kun and Luo, Yang and Hu, Yong},
  title = {Prognostic and Therapeutic Significance of Cancer‐Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single‐Cell RNA Sequencing Data},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70424}
}
Kostenlos starten →